FDA Granted Fast-Track Approval to Now Recalled Zimmer Shoulder Implants

FDA Granted Fast-Track Approval to Now Recalled Zimmer Shoulder Implants

Zimmer Biomet Shoulder Implants were able to obtain approval of its Comprehensive Reverse Shoulder device without any human testing, but the device was pulled from the market in 2010 after complaints of fracturing.

Zimmer Shoulder Implants FDA fast tracked after recall

The U.S. Food and Drug Administration (FDA) approved the Zimmer Shoulder Replacement device through its controversial 510(k) protocol rather than the lengthy and more thorough standard premarket approval process.

The 510(k) process allows a device to be approved on a “fast-track” basis if it can be shown to be substantially similar to a previously approved product already on the market.

In 2008, Zimmer told the FDA that the Comprehensive Reverse Shoulder was substantially equivalent to five different systems on the market at the time, one made by Biomet and the others by Zimmer (they were separate companies until Zimmer purchased Biomet in 2014 for $13.4 billion).

Table of Contents

Zimmer Shoulder Implants Complications

In 2010, the FDA issued a Class II recall of the Biomet shoulder replacement, meaning that the device could cause temporary or reversible complications.

Six years later after multiple incidents of fracturing, the recall was upgraded to a Class I, the most serious type of recall the FDA issues.

According to the FDA, Zimmer Biomet Reverse Shoulder Injuries such as these fractures could result in revision surgeries that could lead to serious health consequences including permanent loss of shoulder function, infection, and even death.

Death related to shoulder implants replacement fractures typically is associated with pulmonary, cardiac, and abdominal complications, according to a study published in the Journal of Shoulder and Elbow Surgery.

Researchers conducting this study found that patients who suffered a fracture after shoulder replacement surgery had a six times higher incidence of death within 30 days than the general population, and concluded that despite advances in technique and implant design, instability after reverse total shoulder replacement surgery remains a distinct possibility for many patients.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources